Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland
· Delayed Price · Currency is CHF
51.60
+0.40 (0.78%)
At close: Dec 5, 2025
Basilea Pharmaceutica AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 634 | 501 | 423 | 546 | 485 | 574 | |
| Market Cap Growth | 31.59% | 18.52% | -22.52% | 12.62% | -15.59% | 14.12% | |
| Enterprise Value | 602 | 551 | 505 | 636 | 551 | 662 | |
| Last Close Price | 51.60 | 41.35 | 35.30 | 45.80 | 40.92 | 53.15 | |
| PE Ratio | 9.43 | 6.46 | 40.47 | 44.94 | - | - | |
| Forward PE | 13.53 | 10.63 | 15.17 | 98.35 | - | - | |
| PS Ratio | 2.68 | 2.40 | 2.68 | 3.69 | 3.27 | 4.50 | |
| PB Ratio | 6.15 | 6.19 | -42.28 | -26.35 | -8.27 | -5.63 | |
| P/TBV Ratio | 6.17 | 6.22 | - | - | - | - | |
| P/FCF Ratio | 8.14 | 6.90 | 31.48 | 139.32 | - | - | |
| P/OCF Ratio | 7.98 | 6.74 | 29.69 | 77.36 | - | - | |
| EV/Sales Ratio | 2.55 | 2.64 | 3.20 | 4.31 | 3.72 | 5.19 | |
| EV/EBITDA Ratio | 7.51 | 8.72 | 21.78 | 29.31 | 154.82 | - | |
| EV/EBIT Ratio | 7.87 | 8.93 | 23.05 | 30.58 | 183.33 | - | |
| EV/FCF Ratio | 7.73 | 7.58 | 37.59 | 162.43 | - | - | |
| Debt / Equity Ratio | 0.94 | 1.38 | -12.86 | -9.03 | -3.74 | -2.37 | |
| Debt / EBITDA Ratio | 1.21 | 1.71 | 5.05 | 7.76 | 41.61 | - | |
| Debt / FCF Ratio | 1.24 | 1.54 | 9.57 | 47.76 | - | - | |
| Asset Turnover | 1.08 | 0.97 | 0.80 | 0.63 | 0.62 | 0.57 | |
| Inventory Turnover | 4.69 | 3.99 | 4.13 | 4.18 | 5.33 | 6.11 | |
| Quick Ratio | 5.40 | 3.93 | 2.48 | 1.96 | 1.22 | 3.87 | |
| Current Ratio | 6.32 | 4.85 | 3.20 | 2.34 | 1.38 | 4.46 | |
| Return on Equity (ROE) | 121.15% | 218.58% | - | - | - | - | |
| Return on Assets (ROA) | 21.88% | 17.89% | 6.95% | 5.56% | 0.79% | -5.93% | |
| Return on Capital (ROIC) | 29.07% | 24.78% | 9.61% | 7.96% | 1.25% | -10.88% | |
| Return on Capital Employed (ROCE) | 35.70% | 29.10% | 17.40% | 14.30% | 4.10% | -11.90% | |
| Earnings Yield | 11.46% | 15.48% | 2.47% | 2.23% | -1.41% | -2.56% | |
| FCF Yield | 12.29% | 14.50% | 3.18% | 0.72% | -6.73% | -9.74% | |
| Buyback Yield / Dilution | -15.14% | -14.10% | -1.67% | -2.24% | -13.62% | 4.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.